2024-10-22 16:34:52
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital
Corporate/ 2023-07-24
HanBio Therapeutics Announces the Comple...

SHANGHAI,Jan. 29,2022-- HanBio Therapeutics ("HanBio"),a biotechnology company committed to researching and developing next genera...

Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement
Corporate/ 2023-07-24
Exopharm and Astellas Institute for Rege...

Astellas Institute for Regenerative Medicine (AIRM) is a subsidiary of Astellas Pharma Inc.,a top 20 global pharmaceutical company

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release